Strategies of Screening for Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy
Abstract
In a recent article, Newman et al1Newman D.B. Miranda W.R. Matern D. et al.Cost efficacy of α-galactosidase A enzyme screening for Fabry disease.Mayo Clin Proc. 2019; 94: 84-88Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar presented the results of screening for Fabry disease in 1192 adult patients with suspected hypertrophic cardiomyopathy and compared the cost efficacy of α-galactosidase A (α-gal A) measurement with...
Paper Details
Title
Strategies of Screening for Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy
Published Date
Aug 1, 2019
Journal
Volume
94
Issue
8
Pages
1644 - 1646
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History